Lilly Mounjaro approved to cut cardiovascular risk (LLY:NYSE)

jetcityimage/iStock Editorial via Getty Images Eli Lilly (LLY) announced on Friday that the FDA has approved a label expansion for its blockbuster GLP-1 drug Mounjaro (tirzepatide) to lower the risk of major adverse cardiovascular events such as stroke in adults with type 2 diabetes. Accordingly, the Source link

Tech’s 3% surge marks only second such S&P 500 split since 2000 (SP500:) (SP500:) (SP500:) (SP500:) (SP500:)

da-kuk/E+ via Getty Images Technology was the only S&P 500 (SP500) sector to gain more than 3% on Thursday while all other sectors closed lower, marking just the second such session since 2000, according to Bluekurtic Market Insights. The previous instance occurred on March Source link

MINISO Group misses Q2 street views (MNSO:NYSE)

MINISO Group Holding press release (MNSO): Q2 Non-GAAP EPADS of $0.26  misses by $0.05. Revenue of $856.2M misses by $3.01M. Gross profit increased 19.6% to $387.6M, with gross margin improving to 45.3% from 44.3%. Adjusted operating profit fell 14.3% to $107.7M, reflecting pressure below the gross-profit lin More on MINISO…

Fundstrat’s Tom Lee remains bullish on Nvidia, seeing it as inexpensive (NVDA:NASDAQ)

Robert Way Fundstrat Head of Research Tom Lee remains bullish on Nvidia (NVDA), arguing that the AI chipmaker still looks inexpensive despite its powerful rally and massive increase in earnings. “The thing that stands out is that Nvidia’s multiple is still very Source link

Here’s why Warsh’s Jackson Hole speech is a major event for bitcoin and gold

Warsh’s Jackson Hole speech could shape expectations for Fed support of Treasury buybacks, with implications for bitcoin, gold and long-term yields. Source link

Up 23% in a month, is the SpaceX share price now expensive… or a bargain?

Never mind the rockets. Just looking at a share price chart for Space Exploration Technologies (NASDAQ: SPCX) can sometimes feel dizzying in itself. The past month alone has seen the SpaceX share price soar 23%. Despite that though, it remains well below the price at which it listed earlier this…